Cite
HARVARD Citation
Guerra Veloz, M. et al. (n.d.). P493 Comparison of the efficacy of infliximab biosimilar (Remsima®) vs. infliximab original (Remicade®) in patients with inflammatory bowel disease. Journal of Crohn's and colitis. pp. S354-S355. [Online].